Catalent Inc (CTLT) Sector
Health Care

(Current) $55.91
1.21 (2.21%) Open Price: 54.82

 

Catalent Inc., a leading global company founded in 1997, plays a critical role in bringing life-saving and life-enhancing drugs to patients worldwide. Headquartered in Somerset, New Jersey, Catalent operates as a trusted partner for pharmaceutical, biopharmaceutical, and consumer health companies. Their expertise lies in the development, manufacturing, and packaging of drugs across various stages, from early development to commercialization.

 

Catalent's comprehensive suite of services spans the entire drug life cycle. They offer expertise in oral dosage forms (tablets, capsules), biologics, and injectables. Early-stage services include formulation development and clinical trial supply management. Catalent then assists with transitioning drugs to commercial production, handling large-scale manufacturing and packaging solutions. This one-stop-shop approach streamlines the drug development process, allowing their partners to focus on research and innovation.

 

Catalent prioritizes quality and patient safety. Their facilities adhere to strict Good Manufacturing Practices (GMP) regulations, ensuring all manufactured products meet the highest quality standards. Additionally, Catalent invests heavily in research and development, continuously innovating their processes and technologies to deliver the most effective drug delivery systems.

 

The pharmaceutical industry is highly competitive, with a constant race to develop and deliver new drugs. However, Catalent's diverse service portfolio, global reach, and commitment to quality position them well in this dynamic environment. They offer their partners a significant advantage by streamlining the development process and ensuring timely delivery of high-quality medications.

 



 

(05/24/24) $54.82
(05/27/24) $54.70
(05/27/24) (Qty.)1,726,171
(05/24/24) $54.70
(05/24/24) $55.18
(05/19/24) $54.52
(05/05/24) $56.73
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing